| Resources & Energy Group Limited (REZ) ORDINARY FULLY PAID |
Materials |
$14 |
Maiden Vat Leach Carbon Strip
|
31 Jan 2025 9:36AM |
$0.029 |
$0.015 |
fallen by
48.28%
|
|
| Almonty Industries Inc (AII) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$104 |
Proposed issue of securities - AII
|
31 Jan 2025 9:36AM |
$1.350 |
$13.240 |
risen by
880.74%
|
|
| TerraCom Limited (TER) ORDINARY FULLY PAID |
Energy |
$53 |
TerraCom Investor Webinar
|
31 Jan 2025 9:36AM |
$0.185 |
$0.066 |
fallen by
64.32%
|
|
| Mastermyne Group Limited (MYE) ORDINARY FULLY PAID |
Materials |
$43 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jan 2025 9:36AM |
$0.160 |
$0.140 |
fallen by
12.50%
|
|
MYE - Price-sensitive ASX Announcement
Full Release
Key Points
- Q2 FY25 EBITDA of $4.1 million, up 14% from prior quarter.
- Revenue decreased to $56.2 million, a 10% decline.
- Net cash of $31.9 million, reflecting fourth consecutive quarter of positive cashflow.
- Contracts extended for operations at Grosvenor, Aquila, and Moranbah North mines.
- New $15 million contract for Ventilation Control Devices at Centurion Mine.
- Twelve month extension for Longwall Services at Narrabri Mine, valued at $15 million.
- Successful launch of a digital training department for Coronado’s Mammoth mine.
- Increased opportunity pipeline with active discussions for new contracts.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Patriot Resources Limited (PAT) ORDINARY FULLY PAID |
Materials |
$11 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jan 2025 9:36AM |
$0.046 |
$0.053 |
risen by
15.22%
|
|
PAT - Price-sensitive ASX Announcement
Full Release
Key Points
- Acquisition of exploration licenses in Zambia.
- Renegotiated terms for the Kitumba Copper Project.
- Continued engagement with the Sandy Lake First Nation regarding Gorman Lithium Project.
- Attempting to sell the Black Hills Projects to maximize value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Core Energy Minerals Ltd (CR3) ORDINARY FULLY PAID |
Materials |
$4 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jan 2025 9:36AM |
$0.024 |
$0.009 |
fallen by
62.50%
|
|
CR3 - Price-sensitive ASX Announcement
Full Release
Key Points
- Core Energy changed its name from Oar Resources Limited to Core Energy Minerals Ltd
- The Company received firm commitment for $750,000 via an unsecured short-term loan
- Experienced uranium geologist Charles Nesbitt was appointed as Exploration Manager
- Christopher Wiener was appointed as Non-Executive Director of the Company
- The Company has entered into options to acquire up to a 100% interest in the Cummins Project and Harris Greenstone Project
- The Company raised gross proceeds of $3.7 million through a two-tranche Placement of new Shares
- Core Energy is excited about the new South Australian Projects and preparing for a maiden drilling campaign at Cummins
- The Amorinópolis Project in Brazil has identified multiple uranium mineralisation occurrences at surface
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pacific Current Group Limited (PAC) ORDINARY FULLY PAID |
Financials |
$300 |
Funds under management as at 31 December 2024
|
31 Jan 2025 9:34AM |
$11.850 |
$10.000 |
fallen by
15.61%
|
|
PAC - Price-sensitive ASX Announcement
Full Release
Key Points
- Total FUM increased to A$30.0 billion from A$28.3 billion as of 31 December 2024.
- Aggregate FUM increased by 6.1% in AUD.
- USD-denominated fund managers experienced a 5.9% decrease in FUM.
- AUD-denominated fund managers saw a 7.3% increase in FUM.
- PAC completed exits from Carlisle Management Company and Banner Oak Capital Partners.
- Improved fundraising momentum is expected in the latter half of the financial year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Peninsula Energy Limited (PEN) ORDINARY FULLY PAID |
Energy |
$283 |
Update on Central Processing Plant Commissioning
|
31 Jan 2025 9:34AM |
$1.315 |
$0.695 |
fallen by
47.15%
|
|
PEN - Price-sensitive ASX Announcement
Full Release
Key Points
- Regulatory inspections and commissioning of the Central Processing Plant at the Lance Uranium Project now scheduled for the June Quarter 2025
- Elution, precipitation and filtration circuits to be sequentially commissioned in advance of the first yellowcake drying unit
- Production of the first dry yellowcake is expected in the June Quarter 2025
- CY2025 production guidance to be revised, with a downgrade likely
- Cash balance of US$44.9m at the end of December 2024 and the Company continues to progress additional funding to decrease liquidity risk through commissioning and ramp up
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pancontinental Energy NL (PCL) ORDINARY FULLY PAID |
Energy |
$91 |
Quarterly Activities Report
|
31 Jan 2025 9:34AM |
$0.017 |
$0.011 |
fallen by
35.29%
|
|
PCL - Price-sensitive ASX Announcement
Full Release
Key Points
- Recent technical studies support case for presence of turbidite reservoir sands.
- Resurgence of exploration and appraisal drilling operations in Namibian Orange Basin.
- Continued drilling success at on-trend Mopane discovery.
- Delivery of Seismic License to Woodside established Long Stop Date as 18 May 2025.
- Quarter-end cash balance of $3.6 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ReNerve Limited (RNV) ORDINARY FULLY PAID |
Health Care |
$15 |
Investor Webinar Update
|
31 Jan 2025 9:33AM |
$0.145 |
$0.110 |
fallen by
24.14%
|
|
| Careteq Limited (CTQ) ORDINARY FULLY PAID |
Health Care |
$3 |
CTQ Q2-FY25 Activities Report & Appendix 4C
|
31 Jan 2025 9:33AM |
$0.012 |
$0.011 |
fallen by
8.33%
|
|
CTQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Integration of EHS and HMR Referrals is progressing well.
- Net cash from operating activities improved to ($0.1 million).
- 1H FY25 unaudited revenue increased to $4 million, up 14% over pcp.
- 1H FY25 unaudited EBITDA for continued operations is $0.4 million.
- Cash balance was $0.85 million at the end of the quarter.
- Focus on growing partnerships in aged care and home care sectors.
- Software platform integration on track for rollout in March.
- Expected annualized savings of $50,000 from decommissioning legacy platforms.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ramelius Resources Limited (RMS) ORDINARY FULLY PAID |
Materials |
$8,142 |
Change in substantial holding
|
31 Jan 2025 9:33AM |
$2.400 |
$4.230 |
risen by
76.25%
|
|
| Prophecy International Holdings Limited (PRO) ORDINARY FULLY PAID |
Information Technology |
$11 |
Prophecy and Securonix enter into Global Reseller Agreement
|
31 Jan 2025 9:33AM |
$0.530 |
$0.145 |
fallen by
72.64%
|
|
PRO - Price-sensitive ASX Announcement
Full Release
Key Points
- Prophecy signs 3 year global reseller agreement with Securonix, Inc.
- Existing and new Securonix customers can purchase Snare, with Prophecy paid per endpoint.
- The partnership is expected to generate over $1M in new ARR in the first 12 months.
- Securonix is a leader in cloud-native Security Information and Event Management (SIEM).
- Prophecy's Snare products will enhance endpoint data collection and visibility.
- The subscription model is based on endpoints managed rather than data volume.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Osteopore Limited (OSX) ORDINARY FULLY PAID |
Health Care |
$2 |
Activities Report December 2024 and Appendix 4C
|
31 Jan 2025 9:33AM |
$0.034 |
$0.007 |
fallen by
80.88%
|
|
OSX - Price-sensitive ASX Announcement
Full Release
Key Points
- Osteopore reports 27% year-over-year revenue growth despite challenges.
- Collaboration with RxCell to expand into scaffold-based cell therapy market.
- Partnership with CytoMed combines Osteopore's scaffolds with mesenchymal stem cells.
- Exclusive distribution agreement signed with Medsite for craniofacial products in Brazil.
- Shareholder support secured for A$20 million redeemable convertible notes issuance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PYC Therapeutics Limited (PYC) ORDINARY FULLY PAID |
Health Care |
$965 |
ADOA Safety Review Committee Approves Dose Escalation
|
31 Jan 2025 9:32AM |
$1.220 |
$1.655 |
risen by
35.66%
|
|
PYC - Price-sensitive ASX Announcement
Full Release
Key Points
- PYC is a clinical-stage biotechnology company.
- PYC-001 targets ADOA, a genetic blinding disease.
- Dose escalation from 3 to 10 micrograms has been approved.
- The trial will continue through 2025.
- There are currently no treatment options available for ADOA.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mesoblast Limited (MSB) ORDINARY FULLY PAID |
Health Care |
$3,554 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jan 2025 9:32AM |
$3.060 |
$2.770 |
fallen by
9.48%
|
|
MSB - Price-sensitive ASX Announcement
Full Release
Key Points
- Ryoncil® became the first MSC therapy approved by U.S. FDA.
- FDA approved Ryoncil® for children aged 2 months and older with SR-aGvHD.
- Commercial inventory manufactured and distribution network established.
- Phase 3 trial of rexlemestrocel-L actively enrolling patients.
- Mesoblast plans to discuss accelerated approval with FDA for heart failure patients.
- Publication in EJHF reported improved survival with Revascor® in heart failure patients.
- Mesoblast raised A$260 million through a private placement.
- Net operating cash spend reduced by 18% compared to prior quarter.
- Cash on hand at end of quarter was US$38 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Botanix Pharmaceuticals Ltd (BOT) ORDINARY FULLY PAID |
Health Care |
$266 |
December 2024 Quarterly Activities Report and Appendix 4C
|
31 Jan 2025 9:32AM |
$0.435 |
$0.135 |
fallen by
68.97%
|
|
BOT - Price-sensitive ASX Announcement
Full Release
Key Points
- First Sofdra prescriptions issued in December 2024.
- Successful Patient Experience Program with 100% refill follow-up in January.
- Full commercial launch of Sofdra underway with trained sales professionals.
- Finalized contracts with key US commercial payers and government payer requirements.
- Q1 CY2025 expected to be the first commercial revenue quarter for Sofdra.
- Cash position reported at A$48.36 million with no debt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sky Metals Limited (SKY) ORDINARY FULLY PAID |
Materials |
$73 |
Investor Presentation
|
31 Jan 2025 9:32AM |
$0.055 |
$0.088 |
risen by
60%
|
|
| QEM Limited (QEM) ORDINARY FULLY PAID |
Materials |
$4 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jan 2025 9:31AM |
$0.069 |
$0.016 |
fallen by
76.81%
|
|
QEM - Price-sensitive ASX Announcement
Full Release
Key Points
- QEM Limited focuses on the Julia Creek Vanadium and Energy Project in Queensland.
- The project holds a JORC (2012) Mineral Resource of 2,870 Mt @ 0.31% V2O5.
- Recent government declarations indicate support for the project and streamline permitting processes.
- QEM raised $2.76 million to fund further development and studies of the project.
- Ongoing environmental monitoring is being conducted to support an Environmental Impact Statement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Micro-X Limited (MX1) ORDINARY FULLY PAID |
Health Care |
$72 |
Trading Halt
|
31 Jan 2025 9:31AM |
$0.078 |
$0.100 |
risen by
28.21%
|
|
MX1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Micro-X Limited has requested a trading halt.
- The halt is effective from 31 January 2025.
- The reason for the halt is a pending announcement regarding a capital raising.
- Trading will resume on 4 February 2025 or when the announcement is made.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| TerraCom Limited (TER) ORDINARY FULLY PAID |
Energy |
$53 |
Quarterly Report - October to December 2024
|
31 Jan 2025 9:31AM |
$0.185 |
$0.066 |
fallen by
64.32%
|
|
TER - Price-sensitive ASX Announcement
Full Release
Key Points
- Total coal sales of 1.6 million tonnes.
- Coal production affected by rainfall, particularly in November and December.
- Blair Athol achieved a saleable coal price increase to A$162.4 per tonne.
- Total equity coal sales amounted to 934 thousand tonnes.
- The company maintains a focus on cost containment and operational efficiencies.
- A fully franked dividend of $0.01 per share was paid for the September 2024 quarter.
- Development of the Moorlands Thermal Coal Project is progressing.
- Sales to Eskom decreased due to road embargoes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Charter Hall Retail REIT (CQR) ORDINARY UNITS FULLY PAID |
Real Estate |
$2,377 |
Substantial Holder Notice for HPI
|
31 Jan 2025 9:30AM |
$3.250 |
$4.090 |
risen by
25.85%
|
|
| Hotel Property Investments (HPI) ORDINARY FULLY PAID |
Real Estate |
- |
Substantial Holder Notice from CQR
|
31 Jan 2025 9:30AM |
$3.750 |
$3.750 |
fallen by
0%
|
|
| Pancontinental Energy NL (PCL) ORDINARY FULLY PAID |
Energy |
$91 |
Appendix 5B
|
31 Jan 2025 9:29AM |
$0.017 |
$0.011 |
fallen by
35.29%
|
|
PCL - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash from operating activities was a loss of $234,000.
- Investing activities resulted in cash outflows of $209,000.
- Total cash and cash equivalents at the end of the quarter were $3,610,000.
- Payments to related parties amounted to $140,000.
- The report complies with ASX listing rules.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PolarX Limited (PXX) ORDINARY FULLY PAID |
Materials |
$57 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jan 2025 9:29AM |
$0.010 |
$0.021 |
risen by
110%
|
|
PXX - Price-sensitive ASX Announcement
Full Release
Key Points
- PolarX Limited reports high-grade copper and silver mineralization at Caribou Dome.
- Drill hole CD24-004 intersected 20.5m at 1.7% copper and 2.5 g/t silver.
- Drill hole CD24-005 revealed 11.6m at 1.8% copper and 2.1 g/t silver.
- Mineralization extends to depths over 300 meters, confirming high-grade potential.
- Results support future underground mine planning and resource estimation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
